Abstract
To the Editor: The use of tumor necrosis factor (TNF)-alpha inhibitors in the management of chronic inflammatory conditions is increasing in dermatology and rheumatology practices. We report a case of an unusual drug eruption in flexural areas occurring in a patient treated with adalimumab for rheumatoid arthritis.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
